Diagnosis of natalizumab-associated progressive multifocal leukoencephalopathy using MRI.
about
Neuroimaging of Natalizumab Complications in Multiple Sclerosis: PML and Other Associated EntitiesAn update on the use of natalizumab in the treatment of multiple sclerosis: appropriate patient selection and special considerationsRevised Recommendations of the Consortium of MS Centers Task Force for a Standardized MRI Protocol and Clinical Guidelines for the Diagnosis and Follow-Up of Multiple SclerosisPML-IRIS during Fingolimod Diagnosed after Natalizumab DiscontinuationHeterogeneous imaging characteristics of JC virus granule cell neuronopathy (GCN): a case series and review of the literature.Current and Emerging Therapies in Multiple Sclerosis: Implications for the Radiologist, Part 2-Surveillance for Treatment Complications and Disease Progression.MRI in the assessment and monitoring of multiple sclerosis: an update on best practice.Advances in and Algorithms for the Treatment of Relapsing-Remitting Multiple SclerosisDiagnostic assays for polyomavirus JC and progressive multifocal leukoencephalopathyProgressive multifocal leukoencephalopathy and immune reconstitution inflammatory syndrome (IRIS).Use of Natalizumab in Patients with Multiple Sclerosis: 2015 Update.Multiple sclerosis update: use of MRI for early diagnosis, disease monitoring and assessment of treatment related complications.MRI criteria differentiating asymptomatic PML from new MS lesions during natalizumab pharmacovigilance.Diagnostic performance of brain MRI in pharmacovigilance of natalizumab-treated MS patients.MRI characteristics of early PML-IRIS after natalizumab treatment in patients with MS.MRI pattern in asymptomatic natalizumab-associated PML.MRI and multiple sclerosis--the evolving role of MRI in the diagnosis and management of MS: the radiologist's perspective.Imaging spectrum of immunomodulating, chemotherapeutic and radiation therapy-related intracranial effects.Can pulmonary sarcoidosis trigger a progressive multifocal leukoencephalopathy? Considerations from a case series and a review of literature
P2860
Q26781389-C0164AA6-AB82-41CF-B1FC-AFA2BD82565DQ27009769-A18E19F3-1370-4DF2-8D3F-57EB6FA4430DQ30278095-31BFC5AB-79FB-472E-9B21-E117CED6C8C8Q34650456-27CC68B8-3CA5-4CC8-B687-A89F6A7FADECQ35314514-776648FB-9EB1-45C4-933E-B19CF23B77DDQ36352813-D10775AA-E3CA-43A4-B583-A28F6AA6D9E2Q36400004-4C6AB34C-7BA8-4F7E-BC0F-F20CC858D8FDQ36484448-23B23597-1317-4858-8018-ECD72C13D81CQ36942417-96CD71A5-93BF-4845-91FB-D86DB034A67FQ38577593-BDBBDB98-6119-4223-A765-4BCB3126094BQ38616689-6EB8BA82-AAED-4528-8746-4E66782126A8Q39211049-CFE24808-6653-4BD1-8DBA-84D4830E8772Q40619670-3318ADFF-4B29-43D0-AEA3-DA0081010D86Q41126166-CE6D3E38-755C-460C-89FB-96C65356335FQ41361912-B0C5874F-136B-4D8D-B864-690EF4B671D6Q41745436-8D2CC377-2435-4731-96D0-FB6B9CE141E8Q49606221-EA344090-46B8-4DCC-87C4-428EA8B1E962Q50079049-CDDA4AEA-E0C5-4DC6-9EB4-50B3757C7E3EQ59136968-620DFD00-5C1A-48DB-91FA-5B0E9C5F8D59
P2860
Diagnosis of natalizumab-associated progressive multifocal leukoencephalopathy using MRI.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Diagnosis of natalizumab-associated progressive multifocal leukoencephalopathy using MRI.
@ast
Diagnosis of natalizumab-associated progressive multifocal leukoencephalopathy using MRI.
@en
type
label
Diagnosis of natalizumab-associated progressive multifocal leukoencephalopathy using MRI.
@ast
Diagnosis of natalizumab-associated progressive multifocal leukoencephalopathy using MRI.
@en
prefLabel
Diagnosis of natalizumab-associated progressive multifocal leukoencephalopathy using MRI.
@ast
Diagnosis of natalizumab-associated progressive multifocal leukoencephalopathy using MRI.
@en
P1476
Diagnosis of natalizumab-associated progressive multifocal leukoencephalopathy using MRI.
@en
P2093
Mike P Wattjes
P304
P356
10.1097/WCO.0000000000000099
P577
2014-06-01T00:00:00Z